Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
about
The coagulopathy of acute sepsisTolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine SplenocytesProgrammed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for SepsisEmerging therapeutic targets of sepsis-associated acute kidney injury.Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside.Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitisImpact of sepsis on CD4 T cell immunitySIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcomePersistent inflammation and T cell exhaustion in severe sepsis in the elderlyInsights into the apoptotic death of immune cells in sepsis.Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.Year in review 2013: Critical Care--sepsis.Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.Murine lung cancer induces generalized T-cell exhaustion.Getting older can be exhausting.Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort studyThe Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis.TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progressionIncreased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study.Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice.Roles of PD-1, Tim-3 and CTLA-4 in immunoregulation in regulatory T cells among patients with sepsis.Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shockT cells from patients with Candida sepsis display a suppressive immunophenotypeNeuropilin-1highCD4⁺CD25⁺ Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis.Pathophysiology of septic shock: From bench to bedside.A Novel Role for Programmed Cell Death Receptor Ligand-1 (PD-L1) in Sepsis-Induced Intestinal Dysfunction.The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression.Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes.Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.Tuftsin prevents the negative immunoregulation of neuropilin-1highCD4+CD25+Regulatory T cells and improves survival rate in septic mice.Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.Immune Exhaustion and Transplantation.Recent developments in severe sepsis research: from bench to bedside and back.New insights into the gut as the driver of critical illness and organ failure.Emerging infection and sepsis biomarkers: will they change current therapies?Apoptosis-induced lymphopenia in sepsis and other severe injuries.The intestinal microenvironment in sepsis.
P2860
Q26826950-A03E2923-1DC9-4B00-B39C-5740ACCFE978Q27302768-2FAB7005-DE26-4F5E-9E36-9029A61DFF24Q29994668-192AE239-4E33-4FA9-94A5-C6D2358C58BEQ30300333-15E42962-C031-4F74-8FB0-A901B55313EFQ31034415-24E14CC2-19F6-42A2-89CC-C338146C396FQ33723244-708C4B81-7DB6-48C7-AC07-B3DF62F50C19Q33909697-328D271C-EB7C-4993-B4E9-62CDEB0ECAF8Q34341378-0A0B8F44-5C88-4B77-8524-62948E37C825Q34341386-55791F46-9A76-4B71-A12B-9AEA5933D48CQ34501472-7DE3145D-8D6F-46E5-A8A3-1C0CB1B5CBBFQ34920059-C02DDBD2-C65E-4BFD-A426-035CBEFCC295Q34955808-8FF7497A-F6D0-4851-876A-A387B1495E9EQ35091080-3B50903A-E666-4DFC-95D4-84A26E93085DQ35546243-22D019C3-FCC7-4FD1-BE60-25066243AC25Q35562860-6033E3D2-6818-457B-9A73-5564D29F57BFQ35581096-E774C3A5-339B-4DBB-9D11-7713256A04D4Q35763013-91F7D449-E33A-423F-9A32-90B22E1C4A98Q36016266-6F420712-8DE0-42FD-ACDB-0BBABD5EFA4FQ36086026-34754458-A6D3-4418-8167-0AEE39A8218CQ36144601-A57EB92C-7DC7-47F6-B1CD-C29F374CCD97Q36245574-3729051A-0555-4703-BDAE-9B331EAC7C01Q36291613-4A9E71D1-A1FF-49D9-8481-F5390F68FDDCQ36412089-53909A52-E71B-434B-9F8F-5F6A94F37409Q36424717-7C173117-7AE0-4BD9-8DD2-84177A496536Q36480729-7AD55531-3369-4953-B1FE-BF509E6BF043Q36889812-D0E2FAAC-D1EE-4BDD-9F33-6D2364F61575Q36906220-A771AD6F-2281-49BD-9A4B-5FB51CE557ECQ37604045-9F9E702B-3505-4D27-AEA7-6059F3A35B3FQ37624967-A75270CC-904F-4A35-8DB8-5E5BA3F4AF70Q37627857-0F6BE1E1-CB25-453F-85F9-82B01C7F24CBQ37649004-CAD0956B-9565-4F8A-9151-1B0FB7A6788DQ37697220-5AD4BC2B-009D-402F-9ACB-64083492FC72Q38217723-12519E59-53CB-4A07-8337-A66E65B9C561Q38412875-4C143F93-6B5E-4F81-9E53-9325FB4A8A9EQ38686551-279D01FD-EFDB-427D-AC51-AD7E00B8A230Q38724278-17B3FCA6-D951-4DC5-8D31-A7EDF8D09999Q38769949-B1DC0F03-4E45-44A4-83D4-2E530211B3B0Q38929971-D85913A2-77CD-427B-85C2-50A14BE10DCBQ38998292-618C34D4-98F9-4E55-8F7B-B1E5BAB0B32EQ39175222-06CB0447-2969-4D95-A530-497B7AAC2C70
P2860
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting the programmed cell ...... ustion in patients with sepsis
@ast
Targeting the programmed cell ...... ustion in patients with sepsis
@en
type
label
Targeting the programmed cell ...... ustion in patients with sepsis
@ast
Targeting the programmed cell ...... ustion in patients with sepsis
@en
prefLabel
Targeting the programmed cell ...... ustion in patients with sepsis
@ast
Targeting the programmed cell ...... ustion in patients with sepsis
@en
P2093
P2860
P356
P1433
P1476
Targeting the programmed cell ...... ustion in patients with sepsis
@en
P2093
Andriani C Patera
Bryan Sato
Catherine Svabek
David Rasche
JoAnn Suzich
Jonathan Green
Katherine Chang
Nancy Ulbrandt
Paul Robbins
Strother Wilson
P2860
P2888
P356
10.1186/CC13176
P577
2014-01-04T00:00:00Z